Ben-Ismail M, Fekih M, Taktak M, Chelli M
Arch Mal Coeur Vaiss. 1979 Feb;72(2):192-9.
Sixteen pregnancies were followed up in 13 patients with prosthetic heart valves: 8 pregnancies went to term under oral anticoagulation, 4 under heparin and 4 without anticoagulation. 9 healthy normal children were delivered; there were 2 still births and 5 abortions. On the maternal side 3 haemorrhages and thromboembolic episodes which involved 2 patients on heparin, one of whom died, were observed. The following points are apparent from our observations and a review of the existing medical literature: --the risk of thromboembolism is not increased. The marked clotting tendency of maternal blood post-partum contraindicates the withdrawal of anticoagulants during this critical period; --haemorrhagic complications are common with anticoagulants; --foetal loss is greatly increased; --the teratogenecity of vitamin-K antagonists is certain, but the risk is small. The problems of anticoagulation are discussed; theoretically heparin should be given during the 1st trimestre and from the 38th week to the second post-partum week. The patients should be closely supervised by both obstetrician and cardiologist and hospitalisation is advised for the last month of pregnancy. Normal vaginal delivery is usually possible.
对13例人工心脏瓣膜患者的16次妊娠进行了随访:8例在口服抗凝剂情况下足月分娩,4例在肝素抗凝下足月分娩,4例未进行抗凝。共分娩出9名健康正常婴儿;有2例死产和5例流产。在母亲方面,观察到3例出血和血栓栓塞事件,其中2例接受肝素治疗的患者发生此类情况,其中1例死亡。从我们的观察以及对现有医学文献的回顾中可以明显看出以下几点:——血栓栓塞风险并未增加。产后母亲血液明显的凝血倾向表明在此关键时期不应停用抗凝剂;——抗凝剂常见出血并发症;——胎儿丢失显著增加;——维生素K拮抗剂的致畸性是肯定的,但风险较小。讨论了抗凝问题;理论上,应在妊娠第一期以及从第38周开始至产后第二周给予肝素。患者应由产科医生和心脏病专家密切监护,建议在妊娠最后一个月住院。通常可以进行正常阴道分娩。